CONGRESS 2023 - Advancing Haematology Morphology Online
Promoting and supporting training and education is an integral part of the work of UK NEQAS. As such the online Digital Morphology for CPD scheme (DM) was introduced some years ago as a companion to our glass-slide blood films for morphology (BF) EQA scheme. DM has been very successful and registration currently stands at just over 4,000 participants. DM recently underwent a major change when it was moved to a new platform and is now hosted on the UK NEQAS Haematology EQATE system. The new EQATE platform offers significant flexibility over the old and allows for the development of additional modules, for example the recently introduced Haemosiderin cytochemistry EQA. Other new modules and features are proposed with some actively under design and testing. This presentation will look at how Digital Morphology and the EQATE platform have evolved, where we are with regards to the currently available modules, some of the challenges we face and a look at some future developments.
Download as vCalendar (for Microsoft Outlook etc.)
Import event to your Google Calendar
Promoting and supporting training and education is an integral part of the work of UK NEQAS. As such the online Digital Morphology for CPD scheme (DM) was introduced some years ago as a companion to our glass-slide blood films for morphology (BF) EQA scheme. DM has been very successful and registration currently stands at just over 4,000 participants. DM recently underwent a major change when it was moved to a new platform and is now hosted on the UK NEQAS Haematology EQATE system.
The new EQATE platform offers significant flexibility over the old and allows for the development of additional modules, for example the recently introduced Haemosiderin cytochemistry EQA. Other new modules and features are proposed with some actively under design and testing. This presentation will look at how Digital Morphology and the EQATE platform have evolved, where we are with regards to the currently available modules, some of the challenges we face and a look at some future developments.